225 related articles for article (PubMed ID: 15817883)
1. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery.
Shiga N; Hirano K; Hirano M; Nishimura J; Nawata H; Kanaide H
Circ Res; 2005 May; 96(9):1014-21. PubMed ID: 15817883
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
Nagaoka T; Hein TW; Yoshida A; Kuo L
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
[TBL] [Abstract][Full Text] [Related]
3. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC.
Takeuchi S; Kawashima S; Rikitake Y; Ueyama T; Inoue N; Hirata K; Yokoyama M
Biochem Biophys Res Commun; 2000 Mar; 269(1):97-102. PubMed ID: 10694484
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
5. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension.
Budzyn K; Marley PD; Sobey CG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1248-53. PubMed ID: 15743931
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
Bolz SS; Vogel L; Sollinger D; Derwand R; de Wit C; Loirand G; Pohl U
Circulation; 2003 Jun; 107(24):3081-7. PubMed ID: 12796138
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
10. Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells.
Yufu T; Hirano K; Bi D; Hirano M; Nishimura J; Iwamoto Y; Kanaide H
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1506-11. PubMed ID: 15860737
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
12. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
Kansui Y; Fujii K; Goto K; Oniki H; Iida M
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
[TBL] [Abstract][Full Text] [Related]
13. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
Eto M; Rathgeb L; Cosentino F; Kozai T; Lüscher TF
J Cardiovasc Pharmacol; 2006 May; 47(5):663-7. PubMed ID: 16775505
[TBL] [Abstract][Full Text] [Related]
14. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
[TBL] [Abstract][Full Text] [Related]
15. Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism.
Wang S; Wright G; Harrah J; Touchon R; McCumbee W; Geng W; Fultz ME; Abdul-Jalil MN; Wright GL
Can J Physiol Pharmacol; 2000 Jun; 78(6):500-6. PubMed ID: 10914640
[TBL] [Abstract][Full Text] [Related]
16. Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.
Alvarez De Sotomayor M; Herrera MD; Marhuenda E; Andriantsitohaina R
Br J Pharmacol; 2000 Nov; 131(6):1179-87. PubMed ID: 11082126
[TBL] [Abstract][Full Text] [Related]
17. Statin-mediated inhibition of Rho: only to get more NO?
Brandes RP
Circ Res; 2005 May; 96(9):927-9. PubMed ID: 15890979
[No Abstract] [Full Text] [Related]
18. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
[TBL] [Abstract][Full Text] [Related]
19. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.
Löhn M; Steioff K; Bleich M; Busch AE; Ivashchenko Y
Eur J Pharmacol; 2005 Jan; 507(1-3):179-86. PubMed ID: 15659308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
